Veeda Lifesciences Invests in Mango Sciences for AI-Driven Clinical Trials Innovation

Veeda Lifesciences Invests in Mango Sciences for AI-Driven Clinical Trials Innovation

Veeda Lifesciences is investing in Mango Sciences to enhance its clinical trial services through AI technology. This partnership aims to improve patient recruitment and streamline processes, particularly in oncology, by leveraging Mango's Querent™ platform. This strategic move strengthens Veeda's position in the CRO sector.

Veeda Lifesciences announces partnership with Mango Sciences to bring AI innovation in clinical trials services

/PRNewswire/ -- Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in Mango Sciences, a Boston-based healthcare AI...

Invest: Veeda to leverage Mango AI capabilities

Dr Misra integrating LLM-Gen-AI into Querent™ for efficiencies Veeda Lifesciences, a global contract research organization (CRO) from Ahmedabad, is investing Mango Sciences, a Boston-based healthcare AI and data company to leverage AI capabilities to enhance the speed, efficiency, and quality of Clinical Trials services across its expanded global network, enabling more diverse, efficient recruitment and […] Source

Veeda Lifesciences invests in Mango Sciences to integrate AI into global clinical trial operations - Express Pharma

Veeda Lifesciences, a global contract research organisation (CRO), has announced an investment in Mango Sciences, a Boston-based healthcare AI and data company. The investment is part of Veeda’s strategy to integrate artificial intelligence into its clinical trial operations, with a focus on improving patient recruitment, trial efficiency, and diversity across global markets. Through this partnership, Veeda will leverage Mango Sciences’ AI platf…